14th May 2007 16:25
As a result of the mapping of the human genome, genetic researchis impacting scientific discovery in profound ways. This includeseverything from understanding the underlying causes of diseases to theregulation of cellular functions, faster disease detection and thecreation of new drugs. To speak about these topics, CEOs fromMyconostica, Ltd., Motif BioSciences, Inc. and WellGen, Inc. willshare exciting new research trends from the world of genetics. £ The Genetics Symposium is sponsored by Amphion Innovations, plc,(LSE: AMP) a developer of companies planning to commercializeintellectual property in life sciences and technology. Amphion'smanagement team has created more than US $14B in aggregate marketcapitalization and has played an instrumental role in co-foundingcompanies, such as Celgene (NASD: CELG) and Medisense (NYSE: ABT). \* TWHAT:Amphion Innovations plc, a developer of life science and technologybusinesses, will introduce the work of its Partner Companies andshowcase its proven model for commercializing highly disruptive IP. WHO:Mr. Richard Morgan, CEO Amphion Innovations plc will describeAmphion's approach to building $100 million plus businesses in the UKand US markets Dr. David Denning, CEO Myconostica, Ltd. will speak on the use ofmolecular genetics for rapid diagnosis of deadly infections Mr. Zaki Hosny, CEO Motif BioSciences, Inc. will speak on howpopulation genetics is being used to isolate certain diseasemutations, such as diabetes and autism Dr. Kathleen Mullinix, CEO WellGen, Inc. will discuss developingfunctional foods and screening for natural ingredients that affectgene expression WHERE:American Conference Centers, 780 Third Avenue (48/49 St.) New YorkCity WHEN:May 15th, from 4:30-7:00 PM. Refreshments will be served. To confirm your presence at the symposium or to receive additionalinformation, please contact: Nicole Allen/Josh Berkman(646) 747-7161 or (917) 528-1066/(646) 747-7158 or [email protected]/[email protected]\* T Copyright Business Wire 2007Related Shares:
AMP.L